Nuveen
LEGN icon

Nuveen’s Legend Biotech LEGN Stock Holding History

Nuveen’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.32M Buy
115,112
+18,326
+19% +$494K ﹤0.01% 2318
2026
Q1 		$1.75M Buy
96,786
+2,200
+2% +$41.9K ﹤0.01% 2324
2025
Q4 		$2.06M Sell
94,586
-1,300
-1% -$37.2K ﹤0.01% 2280
2025
Q3 		$3.13M Sell
95,886
-20,100
-17% -$742K ﹤0.01% 2122
2025
Q2 		$4.12M Sell
115,986
-54,200
-32% -$1.76M ﹤0.01% 1974
2025
Q1 		$5.77M Buy
170,186
+59,600
+54% +$2.14M ﹤0.01% 1842
2024
Q4 		$3.6M Buy
110,586
+5,700
+5% +$236K ﹤0.01% 2126
2024
Q3 		$5.11M Buy
104,886
+4,300
+4% +$229K ﹤0.01% 1978
2024
Q2 		$4.45M Sell
100,586
-1,500
-1% -$69.2K ﹤0.01% 2011
2024
Q1 		$5.73M Sell
102,086
-56,485
-36% -$3.41M ﹤0.01% 1919
2023
Q4 		$9.54M Buy
158,571
+19,600
+14% +$1.24M ﹤0.01% 1606
2023
Q3 		$9.33M Buy
138,971
+21,666
+18% +$1.5M ﹤0.01% 1519
2023
Q2 		$8.1M Sell
117,305
-766
-0.6% -$50.1K ﹤0.01% 1638
2023
Q1 		$5.69M Buy
118,071
+16,500
+16% +$807K ﹤0.01% 1814
2022
Q4 		$5.07M Sell
101,571
-1,700
-2% -$82.4K ﹤0.01% 1895
2022
Q3 		$4.21M Buy
103,271
+6,700
+7% +$314K ﹤0.01% 2001
2022
Q2 		$5.31M Sell
96,571
-7,249
-7% -$306K ﹤0.01% 1900
2022
Q1 		$3.77M Buy
103,820
+10,600
+11% +$419K ﹤0.01% 2206
2021
Q4 		$4.34M Buy
+93,220
New +$4.73M ﹤0.01% 2205

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nuveen's LEGN Position: Q2 2026 in Review

Nuveen increased its Legend Biotech (LEGN) stake by 19% in Q2 2026, buying an estimated $494K and bringing the position to 115,112 shares worth $3.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

Nuveen first reported a position in LEGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $9.54M in Q4 2023. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Nuveen held 115,112 shares of Legend Biotech worth $3.32M as of Q2 2026.
  • Nuveen bought 18,326 Legend Biotech shares in Q2 2026, an estimated $494K.
  • Legend Biotech made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2318 holding.
  • Nuveen first reported a position in Legend Biotech in Q4 2021 and has held it in 19 quarters since.
  • Nuveen's Legend Biotech position peaked at $9.54M in Q4 2023.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.